Endogenous PCSK9 may influence circulating CD45neg/CD34bright and CD45neg/CD34bright/CD146neg cells in patients with type 2 diabetes mellitus

Abstract Protease proprotein convertase subtilisin/kexin type 9 (PCSK9) is a regulator of LDL cholesterol clearance and has been associated with cardiovascular risk. PCSK9 inhibitors increase in vivo circulating endothelial progenitor cells (EPCs), a subtype of immature cells involved in ongoing end...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Romina Tripaldi, Paola Lanuti, Paola Giustina Simeone, Rossella Liani, Giuseppina Bologna, Sonia Ciotti, Pasquale Simeone, Augusto Di Castelnuovo, Marco Marchisio, Francesco Cipollone, Francesca Santilli
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/240420d0916c4f7da323f4207dc7fb87
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires